Rochelle Naylor

A strategic thinker in the application of precision medicine, Dr. Rochelle Naylor serves as an Associate Professor of Pediatrics and Medicine at the University of Chicago. Her academic and clinical pursuits are deeply rooted in the study of monogenic forms of diabetes, with a particular focus on maturity-onset diabetes of the young (MODY). Dr. Naylor's work is pivotal in advancing the understanding and management of this unique form of diabetes, which is often misdiagnosed as more common types of diabetes. Dr. Naylor's research is dedicated to enhancing the cost-effectiveness and accessibility of genetic testing for MODY. She is committed to ensuring that patients receive accurate diagnoses and tailored treatment plans, which are crucial for effective disease management. Her efforts in this area are not only improving patient outcomes but also setting new standards in the field of diabetes care. In her role at the University of Chicago, Dr. Naylor co-manages the Kovler Diabetes Center's Monogenic Diabetes MODY Registry. This registry is a vital resource for both clinicians and researchers, providing valuable data that informs best practices and guides future research endeavors. Her leadership in this initiative underscores her commitment to bridging the gap between research and clinical practice. Dr. Naylor is also actively involved in several national and international initiatives aimed at advancing the field of diabetes research. She plays a key role in the US National Monogenic Diabetes Registry and contributes to the RADIANT study, which seeks to uncover the genetic underpinnings of diabetes. Additionally, her involvement in the American Diabetes Association Precision Medicine in Diabetes Initiative highlights her dedication to integrating cutting-edge research into clinical practice. Her work is characterized by a collaborative approach, engaging with multidisciplinary teams to drive innovation and improve patient care. Dr. Naylor's contributions to the field have been recognized through numerous publications and presentations at national and international conferences, where she shares her insights and findings with the broader medical community. Through her research and clinical efforts, Dr. Naylor is making significant strides in the field of diabetes, particularly in the realm of precision medicine. Her work not only enhances our understanding of MODY but also paves the way for more personalized and effective treatment strategies for patients worldwide.